178 related articles for article (PubMed ID: 28833405)
1. Synthesis and evaluation of novel
Chong Y; Chang J; Zhao W; He Y; Li Y; Zhang H; Qi C
J Labelled Comp Radiopharm; 2018 Feb; 61(2):42-53. PubMed ID: 28833405
[TBL] [Abstract][Full Text] [Related]
2. Metabolic stability of 6,7-dialkoxy-4-(2-, 3- and 4-[18F]fluoroanilino)quinazolines, potential EGFR imaging probes.
Vasdev N; Dorff PN; O'Neil JP; Chin FT; Hanrahan S; VanBrocklin HF
Bioorg Med Chem; 2011 May; 19(9):2959-65. PubMed ID: 21478021
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of novel F-18 labeled 4-aminoquinazoline derivatives: potential PET imaging agents for tumor detection.
Chen Y; Feng M; Li S; Xu J; Ning H; He Y; Wang X; Ding R; Qi C
Bioorg Med Chem Lett; 2012 Jul; 22(14):4745-9. PubMed ID: 22704892
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and pre-clinical evaluation of a new class of high-affinity
Kelly J; Amor-Coarasa A; Nikolopoulou A; Kim D; Williams C; Ponnala S; Babich JW
Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):647-661. PubMed ID: 27847991
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of an
Nunes PSG; Zhang Z; Kuo HT; Zhang C; Rousseau J; Rousseau E; Lau J; Kwon D; Carvalho I; Bénard F; Lin KS
J Labelled Comp Radiopharm; 2018 Apr; 61(4):370-379. PubMed ID: 29247455
[TBL] [Abstract][Full Text] [Related]
6. Radiosynthesis and biological evaluation of fluorine-18 labeled N-acetylgalactosamine derivative [
Sun P; Han Y; Zhu Y; Hu K; Huang S; Tan J; Wang M; Wu H; Tang G
Nucl Med Biol; 2020; 88-89():1-9. PubMed ID: 32580089
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and Bioevaluation of Novel [
Yang X; Wang F; Zhu H; Yang Z; Chu T
Mol Pharm; 2019 May; 16(5):2118-2128. PubMed ID: 30964298
[TBL] [Abstract][Full Text] [Related]
8. Development of [18F]afatinib as new TKI-PET tracer for EGFR positive tumors.
Slobbe P; Windhorst AD; Stigter-van Walsum M; Schuit RC; Smit EF; Niessen HG; Solca F; Stehle G; van Dongen GA; Poot AJ
Nucl Med Biol; 2014 Oct; 41(9):749-57. PubMed ID: 25066021
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and preliminary evaluation of 18F-labeled pyridaben analogues for myocardial perfusion imaging with PET.
Mou T; Zhao Z; Fang W; Peng C; Guo F; Liu B; Ma Y; Zhang X
J Nucl Med; 2012 Mar; 53(3):472-9. PubMed ID: 22302832
[TBL] [Abstract][Full Text] [Related]
10. Radiosynthesis and biological evaluation of
Huang S; Han Y; Chen M; Hu K; Qi Y; Sun P; Wang M; Wu H; Li G; Wang Q; Du Z; Zhang K; Zhao S; Zheng X
Bioorg Med Chem Lett; 2018 Apr; 28(6):1143-1148. PubMed ID: 29486966
[TBL] [Abstract][Full Text] [Related]
11. A Metal-Free DOTA-Conjugated
Roxin Á; Zhang C; Huh S; Lepage M; Zhang Z; Lin KS; Bénard F; Perrin DM
Bioconjug Chem; 2019 Apr; 30(4):1210-1219. PubMed ID: 30896929
[TBL] [Abstract][Full Text] [Related]
12. In Vivo Ester Hydrolysis as a New Approach in Development of Positron Emission Tomography Tracers for Imaging Hypoxia.
Zhang L; Yao X; Cao J; Hong H; Zhang A; Zhao R; Zhang Y; Zha Z; Liu Y; Qiao J; Zhu L; Kung HF
Mol Pharm; 2019 Mar; 16(3):1156-1166. PubMed ID: 30676751
[TBL] [Abstract][Full Text] [Related]
13. One-step ¹⁸F-labeling of carbohydrate-conjugated octreotate-derivatives containing a silicon-fluoride-acceptor (SiFA): in vitro and in vivo evaluation as tumor imaging agents for positron emission tomography (PET).
Wängler C; Waser B; Alke A; Iovkova L; Buchholz HG; Niedermoser S; Jurkschat K; Fottner C; Bartenstein P; Schirrmacher R; Reubi JC; Wester HJ; Wängler B
Bioconjug Chem; 2010 Dec; 21(12):2289-96. PubMed ID: 21082773
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of ¹⁸F-labeled fluoropropyl tryptophan analogs as potential PET probes for tumor imaging.
Chiotellis A; Mu L; Müller A; Selivanova SV; Keller C; Schibli R; Krämer SD; Ametamey SM
Eur J Med Chem; 2013; 70():768-80. PubMed ID: 24239624
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and preclinical evaluation of rhenium and technetium-99m "4 + 1" mixed-ligand complexes bearing quinazoline derivatives as potential EGFR imaging agents.
Kiritsis C; Shegani A; Makrypidi K; Roupa I; Lazopoulos A; Panagiotopoulou A; Triantopoulou S; Paravatou-Petsotas M; Pietzsch HJ; Pelecanou M; Papadopoulos M; Pirmettis I
Bioorg Med Chem; 2022 Nov; 73():117012. PubMed ID: 36155319
[TBL] [Abstract][Full Text] [Related]
16. (18)F Labeled benzimidazole derivatives as potential radiotracer for positron emission tomography (PET) tumor imaging.
Zhang S; Wang X; He Y; Ding R; Liu H; Xu J; Feng M; Li G; Wang M; Peng C; Qi C
Bioorg Med Chem; 2010 Apr; 18(7):2394-401. PubMed ID: 20303769
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and in vitro and in vivo evaluation of SiFA-tagged bombesin and RGD peptides as tumor imaging probes for positron emission tomography.
Lindner S; Michler C; Leidner S; Rensch C; Wängler C; Schirrmacher R; Bartenstein P; Wängler B
Bioconjug Chem; 2014 Apr; 25(4):738-49. PubMed ID: 24666287
[TBL] [Abstract][Full Text] [Related]
18. Fluorine-18 Labeling of the MDM2 Inhibitor RG7388 for PET Imaging: Chemistry and Preliminary Evaluation.
Zhou Z; Zalutsky MR; Chitneni SK
Mol Pharm; 2021 Oct; 18(10):3871-3881. PubMed ID: 34523337
[TBL] [Abstract][Full Text] [Related]
19. The effect of the [18F]-PEG group on tracer qualification of [4-(phenylamino)-quinazoline-6-YL]-amide moiety--an EGFR putative irreversible inhibitor.
Dissoki S; Aviv Y; Laky D; Abourbeh G; Levitzki A; Mishani E
Appl Radiat Isot; 2007 Oct; 65(10):1140-51. PubMed ID: 17574425
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of radiolabeled ML04, a putative irreversible inhibitor of epidermal growth factor receptor, as a bioprobe for PET imaging of EGFR-overexpressing tumors.
Abourbeh G; Dissoki S; Jacobson O; Litchi A; Ben Daniel R; Laki D; Levitzki A; Mishani E
Nucl Med Biol; 2007 Jan; 34(1):55-70. PubMed ID: 17210462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
